Q3 2026 Holdings
Filed 2026-10-30 | 2 holdings | $209.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Mineralys Therapeutics, Inc.(MLYS) | COM | 603170101 | $196.0M | 7,799,518 | 93.4% |
| Phathom Pharmaceuticals, Inc.(PHAT) | COM | 71722W107 | $13.7M | 1,882,039 | 6.6% |